PRKN and Parkinson disease: PD-associated mutations in PINK1 and PARK2 have all been shown to inhibit mitophagy, although individual mutations appear to disrupt different steps of the process (Geisler et al., 2010b,a; Lee et al., 2010; Narendra et al., 2010; Rose et al., 2011).